It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Neutrophils are increasingly implicated in chronic inflammation and metabolic disorders. Here, we show that visceral adipose tissue (VAT) from individuals with obesity contains more neutrophils than in those without obesity and is associated with a distinct bacterial community. Exploring the mechanism, we gavaged microbiome-depleted mice with stool from patients with and without obesity during high-fat or normal diet administration. Only mice receiving high-fat diet and stool from subjects with obesity show enrichment of VAT neutrophils, suggesting donor microbiome and recipient diet determine VAT neutrophilia. A rise in pro-inflammatory CD4+ Th1 cells and a drop in immunoregulatory T cells in VAT only follows if there is a transient spike in neutrophils. Human VAT neutrophils exhibit a distinct gene expression pattern that is found in different human tissues, including tumors. VAT neutrophils and bacteria may be a novel therapeutic target for treating inflammatory-driven complications of obesity, including insulin resistance and colon cancer.
The role of neutrophils is increasingly being recognized in chronic inflammation and metabolic disorders. Here the authors show that visceral adipose tissue from individuals with obesity contains more neutrophils than in those without obesity and is associated with a distinct bacterial community.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Hoyd, Rebecca 2 ; Blaszczak, Alecia M. 1 ; Antwi, Linda 2 ; Jalilvand, Anahita 1 ; Wright, Valerie P. 1 ; Liu, Joey 1 ; Smith, Alan J. 1 ; Bradley, David 1 ; Lafuse, William 3 ; Liu, YunZhou 2
; Williams, Nyelia F. 2
; Snyder, Owen 2 ; Wheeler, Caroline 2 ; Needleman, Bradley 4 ; Brethauer, Stacy 4 ; Noria, Sabrena 4 ; Renton, David 4 ; Perry, Kyle A. 4 ; Nagareddy, Prabha 5 ; Wozniak, Daniel 3
; Mahajan, Sahil 3 ; Rana, Pranav S. J. B. 3
; Pietrzak, Maciej 6 ; Schlesinger, Larry S. 7
; Spakowicz, Daniel J. 2
; Hsueh, Willa A. 1
1 Wexner Medical Center at The Ohio State University, Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
2 Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA (GRID:grid.413944.f) (ISNI:0000 0001 0447 4797)
3 The Ohio State University, Department of Microbial Infection and Immunity, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
4 The Ohio State University, Center for Minimally Invasive Surgery, Department of General Surgery, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
5 Cardiovascular Section University of Oklahoma Health Sciences Center (OUHSC), Department of Internal Medicine, Oklahoma City, USA (GRID:grid.266902.9) (ISNI:0000 0001 2179 3618)
6 The Ohio State University, Department of Biomedical Informatics, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
7 Texas Biomedical Research Institute, Host Pathogen Interactions Program, San Antonio, USA (GRID:grid.250889.e) (ISNI:0000 0001 2215 0219)




